Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis

This study has been completed.

Study NCT00071838 Information provided by National Institutes of Health Clinical Center (CC)

First Received: October 31, 2003 Last Updated: October 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2007
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)